Navigation Links
Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009
Date:6/7/2009

es and results in approximately $174 billion per year in direct and indirect medical expenses.(iii)

According to the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey, approximately 60 percent of people with diabetes do not achieve their target blood sugar levels with their current treatment regimen.(iv) In addition, 85 percent of type 2 diabetes patients are overweight and 55 percent are considered obese.(v) Data support that weight loss (even a modest amount) supports patients in their efforts to achieve and sustain glycemic control.(vi,vii)

About BYETTA(R) (exenatide) injection

BYETTA is the first and only FDA-approved incretin mimetic for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone glucagon like peptide-1 (GLP-1). GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain. BYETTA is approved by the FDA for use by people with type 2 diabetes who are unsuccessful at controlling their blood sugar levels. BYETTA is an add-on therapy for people currently using metformin, a sulfonylurea, or a thiazolidinedione. BYETTA provides sustained A1C control and low incidence of hypoglycemia when used with metformin or a thiazolidinedione, with potential weight loss. BYETTA is not a weight loss product. BYETTA was approved in April 2005 and has been used by more than one million patients since its introduction. For full prescribing information, visit www.BYETTA.com.

Important Safety Information for BYETTA

BYETTA improves glucose (blood sugar) control in adults with type 2 diabetes. It is used with metformin, a sulfonylurea, or a thiazolidinedione. BYETTA is not a substitute for insulin in patients whose diabetes requires insulin treatment. BYETTA is no
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
2. Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
3. Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback
4. After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
5. Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
6. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
7. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
8. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
9. (RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa
10. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
11. Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... China , April 16, 2015 ... leading developer, manufacturer, and marketer of medical devices ... the Securities and Exchange Commission an Annual Report on ... the year ended December 31, 2014. An electronic version ... available on Mindray,s investor relations website at  http://ir.mindray.com ...
(Date:4/16/2015)... OAKS, Calif. , April 16, 2015  Amgen ... report its first quarter financial results on Tuesday, April ... markets. The announcement will be followed by a conference ... Participating in the call from Amgen will be ... and other members of Amgen,s senior management team. ...
(Date:4/16/2015)... 16, 2015  Rosewind Corporation (OTCMKTS: RSWN) announced ... with a newly formed specialty healthcare company focused ... addressing urological disorders. The merged company, which is ... commenced operations and incorporates the pipeline assets of ... strategy is to build a late-stage and commercial ...
Breaking Medicine Technology:Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2Amgen Announces Webcast Of 2015 First Quarter Financial Results 2Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 2Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 3
... Chicago-Area Community Hospital to Offer New Clinical Study to Breast ... ... 29 Little Company of Mary,Hospital and Health Care Centers in ... a new clinical study by Xoft using electronic brachytherapy for the,treatment ...
... Data Posted Online Shows Improvements Across Care Center,Network, ... Fibrosis,Foundation reported today that key indicators of health ... and nutritional status -- are,rising nationwide across its ... outlook for people with CF continues to improve ...
Cached Medicine Technology:Breast Cancer Treatment Is Reduced to One Week 2Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes 2
(Date:4/18/2015)... April 18, 2015 On April 14th, 2015, ... Report , which they say, “exposes a tactical shift by ... malware variants were introduced in 2014 - almost a million ... Day threats to be identified and patched by prominent manufacturers ... clear that doing business in a digital world can be ...
(Date:4/17/2015)... April 18, 2015 Heritage Woods of ... its Supportive Living Week Celebration on April 20 with ... a healthy mind, body and soul. , The community, ... Illinois, serves older adults of all incomes, including those ... independence. , Supportive Living Week is observed every April ...
(Date:4/17/2015)... 2015 Alcohol and Violence , The ... that drinking and driving has been the focus of ... time, the link between alcohol and crime received less ... violence and sexual assault, and their relationship to alcohol ... 5.3 million adults in America were drinking alcohol at ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Consumers who ... protection without modifications can now use the Insurance Pros ... life insurance policy rates that are featured by leading ... standard plans that are offered are mixed between three ... 18 to 79. There are now term, universal and ...
(Date:4/17/2015)... Most dental patients are not aware that nearly ... by foreign dental laboratories, according to the U.S. International ... than 40 states by their respective state boards of ... has created the “What’s In Your Mouth?” ... consequences that could be associated with using poorly-made dental ...
Breaking Medicine News(10 mins):Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2Health News:National Association Urges Transparency in Dental Industry 2
... Sept. 20 Synova Healthcare Group,Inc. (OTC Bulletin Board: ... $3.3 million in aggregate notional principal amount of its,6.5% ... 2012,and related common stock purchase warrants. This sale was ... of notes and warrants in the,aggregate notional principal amount ...
... drug that is used to improve the survival of ... cerebral palsy in those children, according to results from ... Health and led by Ronald Wapner, M.D., professor of ... obstetrician and gynecologist at NewYork-Presbyterian Hospital/Columbia. , Results of ...
... undergo male to female sex-change surgery are happy with the ... a study of over 200 patients in the September issue ... team from the Departments of Urology and Psychiatry at University ... of 222 patients who had undergone surgery and 70 who ...
... secondhand smoke at home are at increased risk of ... the Journal of Adolescent Health. , Our retrospective study ... with academic test performance, said lead author Bradley Collins, ... the Health Behavior Research Clinic at Temple University. , ...
... children and pets,receive regular check-ups. Equally important for ... Not convinced? That cough could be coming from,contaminated ... your carpet be causing,your sinus headache? Wonder about ... (Photo: http://www.newscom.com/cgi-bin/prnh/20070920/NYFNSA01 ) Service Experts, ...
... N.J., Sept. 19, 2007 -- A single dose ... receptor antagonist, resulted in favorable changes in hemodynamics ... in patients with advanced heart failure (ADHF) who ... ToLvaptan on HemodynamIc Parameters in Subjects with HEart ...
Cached Medicine News:Health News:Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants 2Health News:Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants 3Health News:Repeat steroids to premature infants linked to cerebral palsy 2Health News:Most patients who have male-to-female sex-change surgery are happy, despite complications 2Health News:Secondhand smoke increases teen test failure 2Health News:Would Your Home Receive a Passing Grade in Health Care Check-Up? 2Health News:ECLIPSE data on effects of Otsuka's investigational novel treatment, Tolvaptan 2
Controls humeral segments through soft tissue compression while allowing for full range of elbow motion...
... The RCAI Plantar Fasciitis Night Splint ... fasciitis and Achilles tendonitis. It is economical ... adjustable dorsiflexion assist straps for controlled dorsiflexion, ... plantar fascia and Achilles tendon. This feature ...
Comfortably positions the affected foot at 90 to provide continuous and effective stretching of the plantar fascia and Achilles Tendon...
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
Medicine Products: